Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 4/20 | 0.60 |
| ▸ | ESR2 known ✓ | Q92731 | 4/20 | 0.60 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.46 |
| ▸ | DRD1 known ✓ | P21728 | 2/20 | 0.34 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.32 |
| ▸ | GLA known ✓ | P06280 | 1/20 | 0.32 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7202751 | 1.00 | TDP1 (0.86) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL8762761 | 1.00 | TDP1 (0.86) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL1524610 | 1.00 | TDP1 (0.86) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL7930992 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| SCHEMBL852493 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL8372285 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| SCHEMBL1013946 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL9414432 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| Hydrochloric Acid SCHEMBL1584554 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E | |
| SCHEMBL1982595 | 0.96 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 529 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11426712-B2 | Fischer-Tropsch synthesis catalyst containing nitride support, preparation method therefor and use thereof | SYNFUELS CHINA TECHNOLOGY CO., LTD. (CN) | 2022-08-30 | — | — | US | claimed |
| US-20120035385-A1 | SELECTING CATALYST AND CONDITIONS | RINARD CHAUNCEY J (US) | 2012-02-09 | — | — | US | claimed |
| US-20110021460-A1 | SELECTIVE HYDROSILYLATION METHOD AND PRODUCT | MOMENTIVE PERFORMANCE MATERIALS, INC. | 2011-01-27 | — | — | US | claimed |
| US-7605219-B2 | Selective hydrosilylation method with alcohol or epoxide reactant and product | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-10-20 | — | — | US | claimed |
| US-7479559-B2 | 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation | PFIZER INC. (US) | 2009-01-20 | — | — | US | claimed |
| US-20080081924-A1 | SELECTIVE MOLAR EXCESS HYDROSILYLATION METHOD AND PRODUCT | MOMENTIVE PERFORMANCE MATERIALS INC. | 2008-04-03 | — | — | US | claimed |
| US-20080076939-A1 | Two-step process of reacting a dihydroorganosiloxane with a terminally unsaturated compound in the presence of a rhodium catalyst and then with a different unsaturated compound to form an assymetrically disubstitued siloxane; one of the unsaturated compounds is an alkenyl polyalkylene oxide | MOMENTIVE PERFORMANCE MATERIALS INC. | 2008-03-27 | — | — | US | claimed |
| US-20080076896-A1 | SELECTIVE HYDROSILYLATION METHOD AND PRODUCT | MOMENTIVE PERFORMANCE MATERIALS INC. | 2008-03-27 | — | — | US | claimed |
| US-20080076894-A1 | SELECTIVE HYDROSILYLATION METHOD WITH ALCOHOL OR EPOXIDE REACTANT AND PRODUCT | MOMENTIVE PERFORMANCE MATERIALS INC. | 2008-03-27 | — | — | US | claimed |
| US-20080033136-A1 | SELECTIVE HYDROSILYLATION CONDITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2008-02-07 | — | — | US | claimed |
| WO-2006120472-A2 | NOVEL BETA-STEROID COMPOUNDS | GUY'S AND ST THOMAS'NHS FOUNDATION TRUST (GB) | 2006-11-16 | — | — | WO | claimed |
| US-20050245521-A1 | Novel benayl(idene)-lactam derivatives | PFIZER INC. | 2005-11-03 | — | — | US | claimed |
| US-6838182-B2 | Low temperature, fast curing silicone compositions | HENKEL CORPORATION (US) | 2005-01-04 | — | — | US | claimed |
| US-6573328-B2 | Miniature electronics, blend of silicon, crosslinker, catalyst | LOCTITE CORPORATION | 2003-06-03 | — | — | US | claimed |
| US-5312885-A | Complex rhodium catalyst | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1994-05-17 | — | — | US | claimed |
| US-4879070-A | HYDROGEN, CARBON DIOXIDE, TERTIARY AMINE, RHODIUM-ORGANOPHOSPHORUS CATALYST | BP CHEMICALS LIMITED (GB) | 1989-11-07 | — | — | US | claimed |
| EP-0219949-A2 | Preparation of high-purity silyl ketene acetals | DOW CORNING CORPORATION (US) | 1987-04-29 | — | — | EP | claimed |
| US-4579963-A | Organosilicon compound and a room temperature curable organopolysiloxane composition formulated therewith | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1986-04-01 | — | — | US | claimed |
| US-4544770-A | OF UNSATURATED PHOSPHONIUM COMPOUNDS | HOFFMANN-LA ROCHE INC. (US) | 1985-10-01 | — | — | US | claimed |
| US-4031150-A | Catalytic dimerization of norbornadiene to Binor-S | SUNTECH, INC. (US) | 1977-06-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035385-A1 | SELECTING CATALYST AND CONDITIONS | ALG3, MMS19, CAD | ESR1 477/4885ESR2 2354/4885GAA 2680/4885 |
| US-20080076939-A1 | Two-step process of reacting a dihydroorganosiloxane with a terminally unsaturated compound in the presence of a rhodium catalyst and then with a different unsaturated compound to form an assymetrically disubstitued siloxane; one of the unsaturated compounds is an alkenyl polyalkylene oxide | SQLE, HRH3, HMOX2 | ESR1 677/4885ESR2 376/4885GAA 4147/4885 |
| US-20050245521-A1 | Novel benayl(idene)-lactam derivatives | HTR1E, HTR1D, HTR1A | ESR1 351/4885ESR2 329/4885GAA 3035/4885 |
| US-20110021460-A1 | SELECTIVE HYDROSILYLATION METHOD AND PRODUCT | HRH3, HRH4, H1-0 | ESR1 1082/4885ESR2 971/4885GAA 4250/4885 |
| US-20080081924-A1 | SELECTIVE MOLAR EXCESS HYDROSILYLATION METHOD AND PRODUCT | HRH3, HRH4, B2M | ESR1 1274/4885ESR2 1064/4885GAA 4479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.